Cargando…

Association Between ABCB1 Polymorphism and Stable Warfarin Dose Requirements in Brazilian Patients

The ideal dose of the oral anticoagulant warfarin varies widely among patients, mainly due to genetic factors. Genetic variations that impact warfarin pharmacokinetics and the vitamin K cycle are plausible candidates for being associated with warfarin dose requirements. Therefore, the aim of this st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tavares, Letícia C., Marcatto, Leiliane R., Soares, Renata A. G., Krieger, Jose E., Pereira, Alexandre C., Santos, Paulo C. J. L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975540/ https://www.ncbi.nlm.nih.gov/pubmed/29875668 http://dx.doi.org/10.3389/fphar.2018.00542

Ejemplares similares

Pharmaceutical Care Increases Time in Therapeutic Range of Patients With Poor Quality of Anticoagulation With Warfarin
por: Marcatto, Leiliane Rodrigues, et al.
Publicado: (2018)

Machine Learning for Prediction of Stable Warfarin Dose in US Latinos and Latin Americans
por: Steiner, Heidi E., et al.
Publicado: (2021)

Evaluation of the Long-Term Impact on Quality After the End of Pharmacist-Driven Warfarin Therapy Management in Patients With Poor Quality of Anticoagulation Therapy
por: Marcatto, Leiliane Rodrigues, et al.
Publicado: (2020)

CYP2C19 and ABCB1 gene polymorphisms are differently distributed according to ethnicity in the Brazilian general population
por: Santos, Paulo CJL, et al.
Publicado: (2011)

Age is associated with time in therapeutic range for warfarin therapy in patients with atrial fibrillation
por: Marcatto, Leiliane Rodrigues, et al.
Publicado: (2016)

Evaluation of a pharmacogenetic-based warfarin dosing algorithm in patients with low time in therapeutic range – study protocol for a randomized controlled trial
por: Marcatto, Leiliane Rodrigues, et al.
Publicado: (2016)

Multi‐site Investigation of Genetic Determinants of Warfarin Dose Variability in Latinos
por: El Rouby, Nihal, et al.
Publicado: (2020)

Nuclear receptor gene polymorphisms and warfarin dose requirements in the Quebec Warfarin Cohort
por: Shahabi, Payman, et al.
Publicado: (2018)

Characterizing variability in warfarin dose requirements in children using modelling and simulation
por: Hamberg, Anna-Karin, et al.
Publicado: (2014)

Influence of ABCB1 Gene Polymorphism on Rivaroxaban Blood Concentration and Hemorrhagic Events in Patients With Atrial Fibrillation
por: Wang, Yan, et al.
Publicado: (2021)

Pharmacogenetics-based population pharmacokinetic analysis and dose optimization of valproic acid in Chinese southern children with epilepsy: Effect of ABCB1 gene polymorphism
por: Shen, Xianhuan, et al.
Publicado: (2022)

Meta-Analysis of ABCG2 and ABCB1 Polymorphisms With Sunitinib-Induced Toxicity and Efficacy in Renal Cell Carcinoma
por: Sun, Fengjun, et al.
Publicado: (2021)

Simultaneous Use of Amiodarone Influences Warfarin Maintenance Dose but Is Not Associated with Adverse Events
por: Santos, Paulo Caleb Junior Lima, et al.
Publicado: (2014)

Ethnic Diversity and Warfarin Pharmacogenomics
por: Asiimwe, Innocent G., et al.
Publicado: (2022)

Cloning and Transcriptional Activity Analysis of the Porcine Abcb1 Gene Promoter: Transcription Factor Sp1 Regulates the Expression of Porcine Abcb1
por: Guo, Tingting, et al.
Publicado: (2018)

Effect of Standardized Warfarin Treatment Protocol on Anticoagulant Effect: Comparison of a Warfarin Medication Therapy Adherence Clinic with Usual Medical Care
por: Aidit, Salihah, et al.
Publicado: (2017)

ABCB1 and ABCG2 Together Limit the Distribution of ABCB1/ABCG2 Substrates to the Human Retina and the ABCG2 Single Nucleotide Polymorphism Q141K (c.421C> A) May Lead to Increased Drug Exposure
por: El Biali, Myriam, et al.
Publicado: (2021)

Rivaroxaban-Induced Hemorrhage Associated with ABCB1 Genetic Defect
por: Ing Lorenzini, Kuntheavy, et al.
Publicado: (2016)

LPA rs10455872 polymorphism is associated with coronary lesions in Brazilian patients submitted to coronary angiography
por: Santos, Paulo CJL, et al.
Publicado: (2014)

Pharmacogenetic-Guided Algorithm to Improve Daily Dose of Warfarin in Elder Han-Chinese Population
por: Ren, Yirong, et al.
Publicado: (2020)

Machine Learning Algorithm for Predicting Warfarin Dose in Caribbean Hispanics Using Pharmacogenetic Data
por: Roche-Lima, Abiel, et al.
Publicado: (2020)

MYLIP p.N342S polymorphism is not associated with lipid profile in the Brazilian population
por: Santos, Paulo C J L, et al.
Publicado: (2012)

Antimicrobial Peptide Reverses ABCB1-Mediated Chemotherapeutic Drug Resistance
por: Luo, Xiaofang, et al.
Publicado: (2020)

Itraconazole Reverts ABCB1-Mediated Docetaxel Resistance in Prostate Cancer
por: Lima, Thiago S., et al.
Publicado: (2022)

Warfarin Pharmacogenetics: Challenges and Opportunities for Clinical Translation
por: Limdi, Nita A.
Publicado: (2012)

Implications of Polymorphisms in the BCKDK and GATA‐4 Gene Regions on Stable Warfarin Dose in African Americans
por: Bargal, Salma A., et al.
Publicado: (2020)

Limited Sampling Modeling for Estimation of Phenotypic Metrics for CYP Enzymes and the ABCB1 Transporter Using a Cocktail Approach
por: Coelho, Eduardo Barbosa, et al.
Publicado: (2020)

SLCO1B1 rs4149056 polymorphism associated with statin-induced myopathy is differently distributed according to ethnicity in the Brazilian general population: Amerindians as a high risk ethnic group
por: Santos, Paulo CJL, et al.
Publicado: (2011)

Tissue Type Differences in ABCB1 Expression and Paclitaxel Tissue Pharmacokinetics in Patients With Esophageal Cancer
por: van Eerden, Ruben A. G., et al.
Publicado: (2021)

ABCB1 Genetic Variants as Predictors of Irinotecan-Induced Severe Gastrointestinal Toxicity in Metastatic Colorectal Cancer Patients
por: Riera, Pau, et al.
Publicado: (2020)

Anticoagulation Quality of Warfarin and the Role of Physician–Pharmacist Collaborative Clinics in the Treatment of Patients Receiving Warfarin: A Retrospective, Observational, Single-Center Study
por: Qiu, Sha, et al.
Publicado: (2021)

Genetic polymorphisms of patients on stable warfarin maintenance therapy in a Ghanaian population
por: Kudzi, William, et al.
Publicado: (2016)

Effect of Gene-Based Warfarin Dosing on Anticoagulation Control and Clinical Events in a Real-World Setting
por: Zhang, Jinhua, et al.
Publicado: (2020)

Simulating clinical trials for model-informed precision dosing: using warfarin treatment as a use case
por: Augustin, David, et al.
Publicado: (2023)

Novel Gene Polymorphisms for Stable Warfarin Dose in a Korean Population: Genome-Wide Association Study
por: Kim, Jung Sun, et al.
Publicado: (2023)

Application of a warfarin dosing calculator to guide individualized dosing versus empirical adjustment after fixed dosing: a pilot study
por: Cai, Xiaofang, et al.
Publicado: (2023)

ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression
por: Singh, A B, et al.
Publicado: (2012)

The MYLIP p.N342S polymorphism is associated with response to lipid-lowering therapy in Brazilian patients with familial hypercholesterolemia
por: Santos, Paulo C.J.L., et al.
Publicado: (2014)

Evaluation of the Effect of Lime Fruit Juice on the Anticoagulant Effect of Warfarin
por: Adepoju, GKA, et al.
Publicado: (2010)

Initiation and Persistence with Warfarin Therapy in Atrial Fibrillation According to Ethnicity
por: Hansen, Carolina Malta, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_645q4gk0rdjs3csgpgtdm1iurt